Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
- 1 February 2008
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 114 (5), 361-374
- https://doi.org/10.1042/cs20070347
Abstract
Adiponectin is a major adipocyte-secreted adipokine abundantly present in the circulation as three distinct oligomeric complexes. In addition to its role as an insulin sensitizer, mounting evidence suggests that adiponectin is an important player in maintaining vascular homoeostasis. Numerous epidemiological studies based on different ethnic groups have identified adiponectin deficiency (hypoadiponectinaemia) as an independent risk factor for endothelial dysfunction, hypertension, coronary heart disease, myocardial infarction and other cardiovascular complications. Conversely, elevation of circulating adiponectin concentrations by either genetic or pharmacological approaches can alleviate various vascular dysfunctions in animal models. Adiponectin exerts its vasculoprotective effects through its direct actions in the vascular system, such as increasing endothelial NO production, inhibiting endothelial cell activation and endothelium–leucocyte interaction, enhancing phagocytosis, and suppressing macrophage activation, macrophage-to-foam cell transformation and platelet aggregation. In addition, adiponectin reduces neointima formation through an oligomerization-dependent inhibition of smooth muscle proliferation. The present review highlights recent research advances in unveiling the molecular mechanisms that underpin the vascular actions of adiponectin and discusses the potential strategies of using adiponectin or its signalling pathways as therapeutic targets to combat obesity-related metabolic and vascular diseases.Keywords
This publication has 101 references indexed in Scilit:
- Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cellsLife Sciences, 2007
- Short-term Treatment of RAW264.7 Macrophages with Adiponectin Increases Tumor Necrosis Factor-α (TNF-α) Expression via ERK1/2 Activation and Egr-1 Expression: ROLE OF TNF-α IN ADIPONECTIN-STIMULATED INTERLEUKIN-10 PRODUCTIONJournal of Biological Chemistry, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Human adiponectin binds to bacterial lipopolysaccharideBiochemical and Biophysical Research Communications, 2006
- Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF ratsBiochemical and Biophysical Research Communications, 2005
- Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuliBiochemical and Biophysical Research Communications, 2005
- Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cellsBiochemical and Biophysical Research Communications, 2005
- Stimulated HSP90 binding to eNOS and activation of the PI3–Akt pathway contribute to globular adiponectin-induced NO production: Vasorelaxation in response to globular adiponectinBiochemical and Biophysical Research Communications, 2005
- Adiponectin differentially regulates cytokines in porcine macrophagesBiochemical and Biophysical Research Communications, 2004
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996